Taste masked compositions of erythromycin a and derivatives thereof
OwnerRahul Dabre, Vishnubhotla Nagaprasad +1inventors
InventorsRahul Dabre, Vishnubhotla Nagaprasad, Rajiv Malik
Life of this patent
Estimating the term…
Loading patent…
OwnerRahul Dabre, Vishnubhotla Nagaprasad +1inventors
InventorsRahul Dabre, Vishnubhotla Nagaprasad, Rajiv Malik
Estimating the term…
A pharmaceutical composition includes erythromycin A or a derivative thereof and alginic acid. The alginic acid provides taste masking of the erythromycin A or derivative. The erythromycin A derivative may be clarithromycin and the alginic acid may be one or both of alginic acid and its salt. The salt may be one or more of sodium alginate and calcium alginate. The pharmaceutical composition may further include one or more of a binder, a disintegrant, a flavoring agent, and a coating. The pharmaceutical composition also may include one or more active ingredients, including omeprazole, metronidazole, amoxicillin, rifampicin, lansoprazole, ciprofloxacin, ethambutol, and ritonavir. The erythromycin A or a derivative thereof and the one or more active ingredients may be combined in a single pharmaceutical composition.
A pharmaceutical composition comprising erythromycin A or a derivative thereof and alginic acid.
A process for preparing a pharmaceutical composition of erythromycin A or derivative thereof, the process comprising:
A method of treating a bacterial infection in a mammal in need of treatment, the method comprising administering a pharmaceutical composition comprising erythromycin A or a derivative thereof and alginic acid.
A method of masking the taste of erythromycin A or a derivative thereof in a pharmaceutical composition, the method comprising mixing the erythromycin A or derivative thereof with alginic acid.
Dependencies are inferred from the claim text.